Celentano Mary A OD is categorized under Physicians Offices in Springfield, MA and active since 2007.
Celentano Mary A OD was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6213200 by the NAICS.
If you are seeking more information, feel free to contact Mary Celentano at the company’s single location by writing to 305 Bicentennial Highway, Springfield, Massachusetts MA 01118 or by phoning (413) 796-6810. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Celentano Mary A OD |
| Contact Person: | Mary Celentano |
| Address: | 305 Bicentennial Highway, Springfield, Massachusetts 01118 |
| Phone Number: | (413) 796-6810 |
| Website Address: | riverbendmedical.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6213200 |
| Share This Business: |
Celentano Mary A OD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6213200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mary Celentano for inquiries that concern Celentano Mary A OD by calling the company number (413) 796-6810, as your correspondence is most welcome. Additionally, the physical location of the single location of Celentano Mary A OD can be found at the coordinates 42.0964,-72.50198 as well as the street address 305 Bicentennial Highway in Springfield, Massachusetts 01118.
For its online presence, you may visit Celentano Mary A OD’s website at riverbendmedical.com and engage with its social media outlets through on Twitter and on Facebook.